New Delhi, July 24 -- India has significantly increased its efforts to combat substandard and spurious drugs in the market, with the government unearthing thousands of such medicines and prosecuting more offenders.
Union health minister J.P. Nadda informed Parliament on Tuesday that a total of 3,104 "not-of-standard quality" (NSQ) drugs and 245 spurious or adulterated medicines were identified in FY25. The number of legal actions initiated against those involved in these illicit activities stood at 961, as against 604 in FY24. A total of 116,323 drug samples were tested last year across the country.
"While 3,104 were found to be NSQ and 245 spurious or adulterated, the number of prosecutions launched significantly increased to 961, indi...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.